Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro

Akane Yonehara, Yuka Tanaka, Kasem Kulkeaw, Takumi Era, Yoichi Nakanishi, Daisuke Sugiyama

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background/Aim: Neuroblastoma is a pediatric solid tumor refractory to eradication by chemotherapy. To determine whether Aloe vera (AV), a pontial anticancer reagent, could be useful in neuroblastoma therapy, we investigated the anti-proliferative effects of an AV protein extract. Materials and Methods: Human neuroblastoma cell lines (IMR-32, TGW, CHP-126 and NBL-S) were cultured with AV protein extract and proliferation status was assessed by cell counting, Ki-67 staining and gene expression. Results: Among tested lines, the number of viable, AV-treated IMR-32 cells significantly decreased 1.98-fold by day 2 and 1.33-fold by day 5 of culture relative to untreated controls (p<0.05). Treatment also decreased the number of Ki-67(+) IMR-32 cells by 13% by day 5 (p<0.05) and, unlike untreated controls, CCND2 mRNA expression levels became undetectable by day 1. Conclusion: AV-protein extract suppresses human IMR-32 neuroblastoma cell proliferation, possibly by suppressing CCND2 transcript levels in vitro.

Original languageEnglish
Pages (from-to)4479-4486
Number of pages8
JournalAnticancer Research
Volume35
Issue number8
Publication statusPublished - Jan 1 2015

Fingerprint

Aloe
Neuroblastoma
Cell Proliferation
Proteins
In Vitro Techniques
Pediatrics
Staining and Labeling
Gene Expression
Drug Therapy
Cell Line
Messenger RNA
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Yonehara, A., Tanaka, Y., Kulkeaw, K., Era, T., Nakanishi, Y., & Sugiyama, D. (2015). Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro. Anticancer Research, 35(8), 4479-4486.

Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro. / Yonehara, Akane; Tanaka, Yuka; Kulkeaw, Kasem; Era, Takumi; Nakanishi, Yoichi; Sugiyama, Daisuke.

In: Anticancer Research, Vol. 35, No. 8, 01.01.2015, p. 4479-4486.

Research output: Contribution to journalArticle

Yonehara, A, Tanaka, Y, Kulkeaw, K, Era, T, Nakanishi, Y & Sugiyama, D 2015, 'Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro', Anticancer Research, vol. 35, no. 8, pp. 4479-4486.
Yonehara A, Tanaka Y, Kulkeaw K, Era T, Nakanishi Y, Sugiyama D. Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro. Anticancer Research. 2015 Jan 1;35(8):4479-4486.
Yonehara, Akane ; Tanaka, Yuka ; Kulkeaw, Kasem ; Era, Takumi ; Nakanishi, Yoichi ; Sugiyama, Daisuke. / Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro. In: Anticancer Research. 2015 ; Vol. 35, No. 8. pp. 4479-4486.
@article{c5d9de5c805647e19620aa5013538b41,
title = "Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro",
abstract = "Background/Aim: Neuroblastoma is a pediatric solid tumor refractory to eradication by chemotherapy. To determine whether Aloe vera (AV), a pontial anticancer reagent, could be useful in neuroblastoma therapy, we investigated the anti-proliferative effects of an AV protein extract. Materials and Methods: Human neuroblastoma cell lines (IMR-32, TGW, CHP-126 and NBL-S) were cultured with AV protein extract and proliferation status was assessed by cell counting, Ki-67 staining and gene expression. Results: Among tested lines, the number of viable, AV-treated IMR-32 cells significantly decreased 1.98-fold by day 2 and 1.33-fold by day 5 of culture relative to untreated controls (p<0.05). Treatment also decreased the number of Ki-67(+) IMR-32 cells by 13{\%} by day 5 (p<0.05) and, unlike untreated controls, CCND2 mRNA expression levels became undetectable by day 1. Conclusion: AV-protein extract suppresses human IMR-32 neuroblastoma cell proliferation, possibly by suppressing CCND2 transcript levels in vitro.",
author = "Akane Yonehara and Yuka Tanaka and Kasem Kulkeaw and Takumi Era and Yoichi Nakanishi and Daisuke Sugiyama",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "35",
pages = "4479--4486",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "8",

}

TY - JOUR

T1 - Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro

AU - Yonehara, Akane

AU - Tanaka, Yuka

AU - Kulkeaw, Kasem

AU - Era, Takumi

AU - Nakanishi, Yoichi

AU - Sugiyama, Daisuke

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background/Aim: Neuroblastoma is a pediatric solid tumor refractory to eradication by chemotherapy. To determine whether Aloe vera (AV), a pontial anticancer reagent, could be useful in neuroblastoma therapy, we investigated the anti-proliferative effects of an AV protein extract. Materials and Methods: Human neuroblastoma cell lines (IMR-32, TGW, CHP-126 and NBL-S) were cultured with AV protein extract and proliferation status was assessed by cell counting, Ki-67 staining and gene expression. Results: Among tested lines, the number of viable, AV-treated IMR-32 cells significantly decreased 1.98-fold by day 2 and 1.33-fold by day 5 of culture relative to untreated controls (p<0.05). Treatment also decreased the number of Ki-67(+) IMR-32 cells by 13% by day 5 (p<0.05) and, unlike untreated controls, CCND2 mRNA expression levels became undetectable by day 1. Conclusion: AV-protein extract suppresses human IMR-32 neuroblastoma cell proliferation, possibly by suppressing CCND2 transcript levels in vitro.

AB - Background/Aim: Neuroblastoma is a pediatric solid tumor refractory to eradication by chemotherapy. To determine whether Aloe vera (AV), a pontial anticancer reagent, could be useful in neuroblastoma therapy, we investigated the anti-proliferative effects of an AV protein extract. Materials and Methods: Human neuroblastoma cell lines (IMR-32, TGW, CHP-126 and NBL-S) were cultured with AV protein extract and proliferation status was assessed by cell counting, Ki-67 staining and gene expression. Results: Among tested lines, the number of viable, AV-treated IMR-32 cells significantly decreased 1.98-fold by day 2 and 1.33-fold by day 5 of culture relative to untreated controls (p<0.05). Treatment also decreased the number of Ki-67(+) IMR-32 cells by 13% by day 5 (p<0.05) and, unlike untreated controls, CCND2 mRNA expression levels became undetectable by day 1. Conclusion: AV-protein extract suppresses human IMR-32 neuroblastoma cell proliferation, possibly by suppressing CCND2 transcript levels in vitro.

UR - http://www.scopus.com/inward/record.url?scp=84939865394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939865394&partnerID=8YFLogxK

M3 - Article

C2 - 26168490

AN - SCOPUS:84939865394

VL - 35

SP - 4479

EP - 4486

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 8

ER -